Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

Andrea Bacigalupo, Teresa Lamparelli, Paolo Bruzzi et al. · Blood · 2001 · 521 citations · Full text

Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

Neil L. Berinstein, A.J. Grillo-López, Christine A. White et al. · Annals of Oncology · 1998 · 520 citations · Full text

Anti-tumor Response, Lymphoid Neoplasia, Hematological Malignancy +10

Rituximab for steroid-refractory chronic graft-versus-host disease

Corey Cutler, David B. Miklos, Haesook T. Kim et al. · Blood · 2006 · 443 citations · Full text

Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation

Andrea Bacigalupo, Teresa Lamparelli, Giovanni Barisione et al. · Biology of Blood and Marrow Transplantation · 2006 · 339 citations · Full text

Late Transplant-related Mortality, Chronic Lung Dysfunction, Transplantation +13

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

Stefanie Sarantopoulos, Kristen E. Stevenson, Haesook T. Kim et al. · Blood · 2009 · 313 citations · Full text